Fig. 2From: Lung adenocarcinoma harboring concomitant SPTBN1-ALK fusion, c-Met overexpression, and HER-2 amplification with inherent resistance to crizotinib, chemotherapy, and radiotherapyHypothetical structure of SPTBN1-ALK fusion gene. SPTBN1-ALK fusion gene was formed by placing SPTBN1 exons 1–6 upstream of ALK exons 20–29, which were separated by small genomic shardsBack to article page